CD4 and cancer: Studies have shown that both human cancer patients and healthy individuals have CD8+ and CD4+ T cells that can respond to factors associated with immune suppression, such as PD-L1 (112), arginase-1 (113), arginase-2 (114), and IDO (115, 116).